Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1997-10-20
|
pubmed:abstractText |
Despite improved detection of mantle cell lymphoma (MCL), results of its treatment with conventional therapies remain disappointing and the survival rate poor. The role of high-dose chemotherapy has recently been investigated but no potential benefit has been clearly established. We report here our experience with MCL patients treated with intensive chemotherapy and autologous stem cell transplantation (ASCT).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0923-7534
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
701-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9296227-Antineoplastic Agents, Alkylating,
pubmed-meshheading:9296227-Cyclophosphamide,
pubmed-meshheading:9296227-Etoposide,
pubmed-meshheading:9296227-Female,
pubmed-meshheading:9296227-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:9296227-Humans,
pubmed-meshheading:9296227-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9296227-Male,
pubmed-meshheading:9296227-Middle Aged,
pubmed-meshheading:9296227-Survival Analysis
|
pubmed:year |
1997
|
pubmed:articleTitle |
Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma.
|
pubmed:affiliation |
Service d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, France.
|
pubmed:publicationType |
Journal Article
|